Phase II study of ruxolitinib in patients with pStat3+ breast cancer.
Nancy U. Lin
Research Funding - Incyte
Rebecca Sue Gelman
No relevant relationships to disclose
Jane E. Brock
No relevant relationships to disclose
Aditya Bardia
No relevant relationships to disclose
Erica L. Mayer
No relevant relationships to disclose
Beth Overmoyer
No relevant relationships to disclose
Vivian Wang
No relevant relationships to disclose
Marie Iannone
No relevant relationships to disclose
Ian E. Krop
No relevant relationships to disclose
Kornelia Polyak
Research Funding - Novartis
Eric P. Winer
No relevant relationships to disclose